The disturbed glucose metabolism, as metabolic vulnerability for FGFR-addicted cancers, especially the corresponding expressional change of HK2, the key rate-limiting glycolytic enzyme, allows us trying to monitor the FGFRi-response by 18F-FDG (an analog of glucose) PET imaging. Here, HK1 is linked to cancer.